Icosavax, Inc.

ICVX · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$92-$67-$19-$5
Dep. & Amort.$1$0$0$0
Deferred Tax$0$1-$0$0
Stock-Based Comp.$22$29$0$0
Change in WC$8-$2$4$1
Other Non-Cash-$1$0$0$0
Operating Cash Flow-$62-$39-$14-$5
Investing Activities
PP&E Inv.-$11-$1-$0$0
Net Acquisitions$158$0$0$0
Inv. Purchases-$221$0$0$0
Inv. Sales/Matur.$63$0$0$0
Other Inv. Act.-$158$0$0$0
Investing Cash Flow-$169-$1-$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$191$0$27
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$10$305$7$27
Financing Cash Flow$10$305$7$27
Forex Effect$0$0$0$0
Net Chg. in Cash-$221$265-$8$22
Supplemental Information
Beg. Cash$281$15$23$1
End Cash$60$281$15$23
Free Cash Flow-$73-$40-$14-$5